TorreyPines Therapeutics to Host First Quarter 2008 Results Conference Call and Webcast

LA JOLLA, Calif., May 12 TorreyPinesTherapeutics, Inc. (Nasdaq: TPTX) today announced that the company willconduct a conference call and audio webcast on Tuesday, May 13, 2008 at11:00 a.m., Eastern Time (ET), in conjunction with the release of itsfinancial results for the first quarter ended March 31, 2008. TorreyPinesanticipates releasing its financial results at 7:30 a.m. ET on Tuesday,May 13, 2008.

To participate in this conference call, dial 719-325-4817, confirmationcode 2644321 shortly before 11:00 a.m. ET. A replay of the call will beavailable from 2:00 p.m. ET. The replay number is 719-457-0820, confirmationcode 2644321. The audio webcast can be accessed at:http://www.torreypinestherapeutics.com.

About TorreyPines Therapeutics

TorreyPines Therapeutics, Inc. is a biopharmaceutical company committed toproviding patients with better alternatives to existing therapies through theresearch, development and commercialization of small molecule compounds. Thecompany's goal is to develop versatile product candidates each capable oftreating a number of acute and chronic diseases and disorders such asmigraine, chronic pain, muscle spasticity and rigidity, xerostomia andcognitive disorders. The company is currently developing four productcandidates: two ionotropic glutamate receptor antagonists and two muscarinicreceptor agonists. Further information is available athttp://www.torreypinestherapeutics.com.Company Contact: Media Contact: Craig Johnson David Schull TorreyPines Therapeutics, Inc. Russo Partners, LLC 858-623-5665, x118 212-845-4271 [email protected] [email protected] Investor Contact: Rhonda Chiger Rx Communications 917-322-2569 [email protected]

SOURCE TorreyPines Therapeutics, Inc.

Latest Press Release on General News

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...

A 2017 Hyundai Elantra and 760,000 kilometres of life-saving blood donation deliveries

Mr. Tim German's 2017 Hyundai Elantra a.k.a. "Dark Angel," was bought new from Steele Hyundai Halifax and now has more than 760,000 kilometres on the odometer. With his Elantra, Mr....

Philips Respironics Reaches Agreement with US Government on a Consent Decree Creating a Clear Path Forward

April 10, 2024 Philips confirms that further to communicating the main terms of the Philips Respironics consent decree on January 29, 2024, Philips’ subsidiaries Philips Holding USA ...